ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ALRN Aileron Therapeutics Inc

4.16
-0.39 (-8.57%)
01 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Aileron Therapeutics Inc ALRN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.39 -8.57% 4.16 15:41:39
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.31 3.70 4.50 4.16 4.55
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202407:45GLOBEAileron Therapeutics Announces Pricing of Underwritten..
01/5/202407:30GLOBEAileron Therapeutics Announces Positive Data from Cohort 1..
15/4/202416:20GLOBEAileron Therapeutics Reports Fourth Quarter and Full Year..
12/3/202407:00GLOBEAileron Therapeutics Announces CEO Transition
06/3/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202406:01EDGAR2Form 8-K - Current report
15/2/202415:05GLOBEAileron Therapeutics and Pulmonary Care Experts To Discuss..
13/2/202406:01EDGAR2Form 8-K - Current report
05/2/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
05/2/202412:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202415:30GLOBEAileron Therapeutics to Host Key Opinion Leader Event on..
31/1/202415:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/1/202415:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/1/202415:10EDGAR2Form S-3 - Registration statement under Securities Act of..
29/1/202407:46EDGAR2Form DEF 14A - Other definitive proxy statements
29/1/202407:14EDGAR2Form 8-K - Current report
25/1/202406:00EDGAR2Form 8-K - Current report
19/1/202415:44EDGAR2Form PRE 14A - Other preliminary proxy statements
11/1/202415:18EDGAR2Form 8-K/A - Current report: [Amend]
10/1/202415:08EDGAR2Form 8-K - Current report
18/12/202316:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202315:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202316:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/11/202319:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202319:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/11/202319:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/10/202311:40EDGAR2Form 8-K - Current report
31/10/202311:30PRNUSAileron Therapeutics Announces Acquisition of Lung..
13/10/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Su Consulta Reciente

Delayed Upgrade Clock